Soleno Therapeutics (SLNO) had the highest return between September 14, 2023 and October 15, 2023 by a mid-cap US stock, returning 492.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
Soleno Therapeutics (SLNO) | 9/14/2023 - 10/15/2023 | 492.91% |
Immunovant (IMVT) | 9/14/2023 - 10/15/2023 | 72.63% |
Steelcase (SCS) | 9/14/2023 - 10/15/2023 | 33.45% |
Scholar Rock (SRRK) | 9/14/2023 - 10/15/2023 | 28.74% |
Frontline (FRO) | 9/14/2023 - 10/15/2023 | 28.17% |
HUTCHMED DRC (HCM) | 9/14/2023 - 10/15/2023 | 27.88% |
Regencell Bioscience (RGC) | 9/14/2023 - 10/15/2023 | 23.09% |
Nuvalent (NUVL) | 9/14/2023 - 10/15/2023 | 22.55% |
Alignment Healthcare LLC (ALHC) | 9/14/2023 - 10/15/2023 | 22.14% |
TAL Education (TAL) | 9/14/2023 - 10/15/2023 | 20.73% |
Ramaco Resources (METCB) | 9/14/2023 - 10/15/2023 | 19.9% |
Abercrombie & Fitch (ANF) | 9/14/2023 - 10/15/2023 | 18.43% |
Ramaco Resources (METC) | 9/14/2023 - 10/15/2023 | 18.09% |
Vista Oil Gas ADR (VIST) | 9/14/2023 - 10/15/2023 | 17.21% |
Sirius XM (SIRI) | 9/14/2023 - 10/15/2023 | 16.03% |
NCR Atleos (NATL) | 9/14/2023 - 10/15/2023 | 15.56% |
CMBTECH (CMBT) | 9/14/2023 - 10/15/2023 | 15.33% |
Torm PLC Class A (TRMD) | 9/14/2023 - 10/15/2023 | 14.41% |
Apellis Pharmaceuticals (APLS) | 9/14/2023 - 10/15/2023 | 13.66% |
USA Compression Partners (USAC) | 9/14/2023 - 10/15/2023 | 13.4% |
Stevanato Group SpA (STVN) | 9/14/2023 - 10/15/2023 | 12.96% |
Alliance Resource Partners (ARLP) | 9/14/2023 - 10/15/2023 | 12.62% |
Vertex (VERX) | 9/14/2023 - 10/15/2023 | 12.54% |
Synaptics (SYNA) | 9/14/2023 - 10/15/2023 | 12.41% |
International Seaways (INSW) | 9/14/2023 - 10/15/2023 | 12.34% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
